奧萊瑪製藥公司
US ˙ NasdaqGS ˙ US68062P1066

SecurityOLMA / Olema Pharmaceuticals, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership3,937,831 shares
Latest Disclosed Value $ 58,713,060
State Street Corp reports 108.97% increase in ownership of OLMA / Olema Pharmaceuticals, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 3,937,831 shares of Olema Pharmaceuticals, Inc. (US:OLMA) valued at $58,713,060 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,884,399 shares of Olema Pharmaceuticals, Inc.. This represents a change in shares of 108.97% during the quarter. The current value of the position is $42,056,035 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 3,937,831 2,053,432 108.97 58,713 24.63 0.0020
2026-02-13 2025-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 1,884,399 790,825 72.32 47,110 340.02 0.0016
2025-11-14 2025-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 1,093,574 41,607 3.96 10,706 138.92 0.0004
2025-08-14 2025-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 1,051,967 186,411 21.54 4,481 37.71 0.0002
2025-05-15 2025-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 865,556 -991,971 -53.40 3,254 -69.95 0.0001
2025-02-14 2024-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 1,857,527 -112,436 -5.71 10,829 -53.96 0.0004
2024-11-14 2024-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 1,969,963 21,986 1.13 23,521 11.60 0.0010
2024-08-14 2024-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 1,947,977 -1,230,450 -38.71 21,077 -41.42 0.0009
2024-05-15 2024-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 3,178,427 2,505,257 372.16 35,980 280.97 0.0016
2024-02-14 2023-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 673,170 114,053 20.40 9,445 36.77 0.0005
2023-11-14 2023-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 559,117 63,417 12.79 6,905 54.27 0.0004
2023-08-14 2023-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 495,700 374,519 309.06 4,476 965.71 0.0002
2023-05-15 2023-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 121,181 12,100 11.09 420 57.30 0.0000
2023-05-15 2022-12-31 13F/A-99 OLEMA PHARMACEUTICALS COM 68062P106 109,081 8,600 8.56 267 -3.61 0.0000
2023-05-15 2022-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 109,081 8,600 267 0.0000
2022-11-15 2022-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 100,481 0 0.00 277 -32.27 0.0000
2022-08-15 2022-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 100,481 -359,072 -78.14 409 -79.11 0.0000
2022-05-16 2022-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 459,553 39,522 9.41 1,958 -50.19 0.0001
2022-02-14 2021-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 420,031 34,201 8.86 3,931 -63.03 0.0002
2021-11-15 2021-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 385,830 181,474 88.80 10,633 85.96 0.0006
2021-08-16 2021-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 204,356 30,510 17.55 5,718 -0.87 0.0003
2021-07-09 2021-03-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 173,846 173,846 5,768 0.0003
2021-05-17 2021-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 173,846 173,846 5,768 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.